BioCatalyst

Efanesoctocog alfa — catalyst calendar

2 verified catalyst event(s) referencing Efanesoctocog alfa, each linked to its official source. Verified as of 2026-11-04.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-17
in 13d
ESTIMATED
 READOUT
A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemo
Phase 4 · Haemophilia A (Moderate or Severe), Hemophilia, Classic
 Swedish Orphan Biovitrum Efanesoctocog alfa ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
Study to Provide Continued Access to Treatment for Patients Completing a Previou
Phase 3 · Haemophilia A (Moderate or Severe)
 Swedish Orphan Biovitrum Efanesoctocog alfa ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.